CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Securing Kids' Futures Requires Strengthening the Pediatric Workforce
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
Securing Kids' Futures Requires Strengthening the Pediatric Workforce
Children’s hospitals are focused on building a workforce to meet children’s needs today and into the future.
March 04, 2026
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
A recent assessment showed children’s hospitals participating in the federal drug pricing discount program save hundreds of millions annually — and invest even more into their communities.
March 03, 2026
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
CHA responded to two proposed rules on Medicaid funding and Hospital Conditions of Participation.
Feb. 18, 2026
